Table 2

Baseline characteristics of included patients stratified by individual cohort

Derivation cohort (n=703)Validation cohort 1 (n=462)Validation cohort 2 (n=191)Validation cohort 3 (n=806)
Age in years, mean (SD)58.6 (14.3)63.8 (15.6)57.0 (14.7)57.9 (13.1)
Men (%)430 (61.2)270 (58.4)122 (63.9)482 (59.8)
Previous angina (%)221 (31.4)185 (40.0)54 (28.3)210 (26.1)
Previous myocardial infarction (%)167 (23.8)138 (29.9)54 (28.3)177 (22.0)
Hypertension (%)343 (48.8)197 (42.6)76 (39.8)455 (56.5)
Hyperlipidaemia (%)339 (48.2)186 (40.3)62 (32.5)534 (66.3)
Diabetes mellitus (%)125 (17.8)80 (17.3)27 (14.1)137 (17.0)
Current smoking (%)216 (30.7)96 (20.8)52 (27.2)192 (23.8)
Previous coronary intervention (%)140 (19.9)101 (21.9)43 (22.5)158 (19.6)
Time from symptom onset to arrival in the ED (median, IQR)2.5 (1.2–5.8)3.4 (1.7–9.1)3.2 (1.4–5.6)2.3 (0.4–4.1)
Outcomes
 Number with AMI (%)130 (18.5)79 (17.1)29 (15.2)64 (7.9)
 Number with ACS (%)151 (21.5)94 (20.3)37 (19.4)81 (10.0)
 Number with death at 30 days (%)5 (0.7)6 (1.3)3 (1.6)1 (0.1)
 Number with incident AMI at 30 days (%)2 (0.3)12 (2.6)0 (0.0)0 (0.0)
 Number with coronary revascularisation at 30 days (%)99 (14.1)46 (10.0)20 (10.5)55 (6.8)
 Number with coronary stenosis at 30 days (%)111 (15.8)55 (11.9)30 (15.7)91 (11.3)
Predictors in the T-MACS model
 Acute ECG ischaemia (%)196 (27.9)105 (22.7)49 (25.7)0 (0.0)
 Worsening angina (%)108 (15.4)94 (20.3)25 (13.1)125 (15.5)
 Patient reports vomiting in association with the chest pain (%)47 (6.7)33 (7.1)10 (5.2)35 (4.3)
 Sweating observed (%)82 (11.7)25 (5.4)13 (6.8)27 (3.3)
 Systolic BP <100 mm Hg (%)23 (3.3)17 (3.7)6 (3.1)27 (3.3)
 hs-cTnT, median (IQR)7.6 (<3–17.5)9.8 (5.3–22.9)4.0 (<3–16.0)7.2 (4.6–11.9)
 hs-cTnT >14 ng/L (%)212 (30.2)181 (39.2)46 (24.1)159 (19.7)
 Pain radiating to right arm or shoulder (%)69 (9.8)59 (12.8)24 (12.6)93 (11.5)
  • ACS, acute coronary syndromes; AMI, acute myocardial infarction; hs-cTnT, high sensitivity cardiac troponin T; T-MACS, Troponin-only Manchester Acute Coronary Syndromes.